Thromboprophylaxis in patients undergoing total hip and knee arthroplasty: a review of current practices in an <scp>A</scp>ustralian teaching hospital

Pow, R E; Vale, Peter R.

doi:10.1111/imj.12675

Cited by 11 publications

(12 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The overall incidence was 4.7% (19/402), with the majority occurring following TKA (6.5%, 13/200). 19 This frequency was congruent with our findings of 6.7% (33/493).…”

Section: Discussionsupporting

confidence: 93%

See 1 more Smart Citation

Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single‐centre, single‐surgeon, retrospective analysis

King

Pow

Dickison

et al. 2016

Internal Medicine Journal

Self Cite

View full text Add to dashboard Cite

show abstract

“…The overall incidence was 4.7% (19/402), with the majority occurring following TKA (6.5%, 13/200). 19 This frequency was congruent with our findings of 6.7% (33/493).…”

Section: Discussionsupporting

confidence: 93%

“…The incidence of in‐hospital VTE in this centre has previously been examined in patients undergoing TKA and THA. The overall incidence was 4.7% (19/402), with the majority occurring following TKA (6.5%, 13/200) . This frequency was congruent with our findings of 6.7% (33/493).…”

Section: Discussionsupporting

confidence: 87%

Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single‐centre, single‐surgeon, retrospective analysis

King

Pow

Dickison

et al. 2016

Internal Medicine Journal

Self Cite

View full text Add to dashboard Cite

show abstract

“… 17 25 Lower compliances for medical than surgical patients in the ENDORSE study and the regional hospital are consistent with the more complex indications in medical patients, and have been noted elsewhere. 26 No equivalent Australian studies could be found for indicators associated with management of suspected or confirmed DVT or PE (CTA compliance 64%), or patients with a documented discharge plan and a date for cessation of treatment (CTA compliance 46%), but it would seem reasonable to conclude that both of these areas of practice also require attention.…”

Section: Discussionmentioning

confidence: 99%

Assessing the appropriateness of prevention and management of venous thromboembolism in Australia: a cross-sectional study

et al. 2016

View full text Add to dashboard Cite

Objectives: The prevention and management of venous thromboembolism (VTE) is often at variance with guidelines. The CareTrack Australia (CTA) study reported that appropriate care (in line with evidencebased or consensus-based guidelines) is being provided for VTE at just over half of eligible encounters. The aim of this paper is to present and discuss the detailed CTA findings for VTE as a baseline for compliance with guidelines at a population level. Setting:The setting was 27 hospitals in 2 states of Australia.Participants: A sample of participants designed to be representative of the Australian population was recruited. Participants who had been admitted overnight during 2009 and/or 2010 were eligible. Of the 1154 CTA participants, 481(42%) were admitted overnight to hospital at least once, comprising 751 admissions. There were 279 females (58%), and the mean age was 64 years.Primary and secondary outcome measures: The primary measure was compliance with indicators of appropriate care for VTE. The indicators were extracted from Australian VTE clinical practice guidelines and ratified by experts. Participants' medical records from 2009 to 2010 were analysed for compliance with 38 VTE indicators.Results: Of the 35 145 CTA encounters, 1078 (3%) were eligible for scoring against VTE indicators. There were 2-84 eligible encounters per indicator at 27 hospitals. Overall compliance with indicators for VTE was 51%, and ranged from 34% to 64% for aggregated sets of indicators.

show abstract

“…Pow and Vale's 20 study in one private hospital in Australia looked at 400 patients undergoing total hip and knee arthroplasty, who received chemical thromboprophylaxis for a minimum of 10 to 14 days. Almost half received LMWH and 125 received aspirin while in hospital.…”

Section: Resultsmentioning

confidence: 99%

A Systematic Review on the Use of Aspirin in the Prevention of Deep Vein Thrombosis in Major Elective Lower Limb Orthopedic Surgery: An Update from the Past 3 Years

Mistry

Chandratreya

Lee

2017

Surg J

View full text Add to dashboard Cite

Introduction Currently there are no consensuses in the national guidance on thromboprophylaxis following major elective lower limb surgery. Emerging clinical evidence suggests that aspirin could be just as effective as anticoagulants with a lower cost. The aim of this study was to provide an update based on literature of the past 3 years for the use of aspirin as thromboprophylaxis after knee and hip arthroplasty. Materials and Methods MEDLINE/EMBASE search was performed with appropriate terms for original articles from 2014 to 2017. Results Eight articles were found. Five articles concluded that aspirin was an effective prophylactic. The collation of results on the deep vein thrombosis rate involved 43,012 patients who were prescribed aspirin, of which 283 (0.66%) suffered from symptomatic deep vein thromboses. Aspirin was noted for its good side effect profile and cost effectiveness. It was noted that anticoagulants had a higher rate of complications, including bleeding and wound-oozing. Conclusion Aspirin is an effective and safe prophylactic against deep vein thrombosis following major elective lower limb arthroplasty surgery.

show abstract

Thromboprophylaxis in patients undergoing total hip and knee arthroplasty: a review of current practices in an Australian teaching hospital

Cited by 11 publications

References 35 publications

Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single‐centre, single‐surgeon, retrospective analysis

Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single‐centre, single‐surgeon, retrospective analysis

Assessing the appropriateness of prevention and management of venous thromboembolism in Australia: a cross-sectional study

A Systematic Review on the Use of Aspirin in the Prevention of Deep Vein Thrombosis in Major Elective Lower Limb Orthopedic Surgery: An Update from the Past 3 Years

Contact Info

Product

Resources

About